Pharmaceutical, Drugs, Medicine, Biology, FDA.
disease. Patient heterogeneity: Nervous system disorders often display significant heterogeneity across patient populations, which can make it difficult to develop drugs that are effective for all patients. Increased clinical phenotyping and endotyping can help to identify patient subgroups that